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It is of critical importance to examine carefully the potential adverse effects of engineered nanoparticles 
(NPs) on human health and environments. In the present study, we have investigated the disruption of 
cell membranes induced by amorphous silica NPs in erythrocytes, lymphocytes (Jurkat), malignant 
melanocytes (B16F10), and macrophages (J774.1); these four types of mammalian cells have distinctive 
characteristics in terms of nucleated/non-nucleated cells, adherent/non-adherent cells, endocytosis, and 
phagocytosis. The silica-induced membranolysis was examined by exposing these different cells to 
serum-free culture media containing the amorphous silica NPs of different diameters (28, 50, 55, 156, 
and 461 nm) under similar conditions. We investigated how the silica-induced membranolysis of the 
cells of different origins is influenced by the size and dose of the silica NPs. Additionally, the interaction 
forces of a silica microsphere with a living cell or a giant unilamellar vesicle composed of zwitterionic 
phosphatidylcholine lipids were measured by colloid-probe atomic force microcopy, whereby the 
affinities of silica surface for plasma membranes and protein-free phospholipid membranes were 
estimated. Possible mechanism of the silica-induced membranolysis was discussed. 
 
Keywords:  







The recent advancement in nanotechnology enables us to produce a variety of functional nanoparticles 
(NPs) with unique physicochemical, optical, and/or electrical properties such as large specific surface 
area, high reactivity, tuned photoluminescence, and high electric conductivity, which differ from those 
of bulk materials of the same composition. The increasing use of these NPs in commercial and 
consumer products has given rise to heightened concern for their biological activity and environmental 
impact. It is therefore of critical importance to address the potential adverse effects of NPs on human 
health and environments. 
In spite of the very simple chemical formula of silicon dioxide (SiO2), silica exists in a very large 
number of different forms, which are characterized by crystallinities and specific physicochemical 
surface properties [1]. Since silica is a common mineral found naturally in sand and rock, silica 
exposure is usual in lots of occupations such as mines and quarries, where inhalation of crystalline silica 
dusts causes a lung disease (silicosis) [2-4]. Recently, the amorphous silica NPs possessing uniform size 
and shape as well as the nonspherical morphologies and/or the mesoporous structures have been 
produced for industrial and biomedical applications [5-9]. For this reason, the effects of silica on human 
health should be still extensively investigated in vitro and in vivo [10-12]. 
The impacts of silica on red blood cells (RBCs) have been investigated; consequently, the silica 
particles are found to exhibit hemolytic activity against washed RBCs in serum-free buffered saline 
within a few fours [13,14], where the hemolytic activity is indicative of the degree of membrane damage. 
The hemolytic activity of silica varies according to the structural forms of silica such as crystallinity [15] 
and porosity [5-9], and is significantly reduced by (pre)treatment of the silica particle surfaces with 
serum [13,16,17], some proteins [16-19], or some chemicals [5-7,14,16,17,20-22]. Nonetheless, the 
hemolytic activity of amorphous silica NPs with uniform size and shape other than crystalline silica 
dusts remains to be explored [7,23]. 
In addition to the hemolytic activity, the cytotoxic effects of silica NPs on various types of cell lines 
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and primary cells (originated from different kinds of tissues and organs) have been examined in terms of 
various cellular responses such as disruption of cell membrane, viability of cells, inhibition of cell 
growth, transformation, and release of various factors (e.g. cytokines): the target cells include 
lymphocytes [24], macrophages [25-31], epithelial cells [28,32-37], endothelial cells [27,38-40], 
mesothelial cells [41], keratinocytes [33,42], fibroblasts [34,37], neuroblasts [24,36], hepatic cells [43], 
myoblasts [44], and kidney cells [45]. The testing strategy and the treatment conditions vary study by 
study, because the robust methodology has not been established for assessing the cytotoxicity of NPs. 
Indeed, the cytotoxicity outcome of NPs is influenced by assay conditions, such as the addition of serum 
or surfactants [28,37] and the procedure/medium for rinsing the cell surfaces before exposure to NPs 
(according to our experience): the former alters the surface properties of NPs and cells, and the latter 
determines whether the serum proteins added in the culture medium and/or the extracellular proteins 
secreted by cells are efficiently removed from the cell surfaces or not. For these reasons, reliable in vitro 
studies must contain the detailed information of the assay conditions, which generates consistent toxicity 
data on NPs. Unfortunately, many of the reported studies lack of such information; this is the case for 
the cytotoxicity studies of silica NPs. 
Our main focus of the present study is placed on the rupture of cell membrane caused by amorphous 
silica NPs, which is considered as a short-time cellular response to high-dose silica NPs [46]. We have 
examined this silica-induced membranolysis by exposing four different types of mammalian cells to 
serum-free media containing the amorphous silica NPs of different diameters (28, 50, 55, 156, and 461 
nm) under similar conditions, whereby the results of membranolysis for the different types of cells can 
be compared with each other. The target cells include erythrocytes (rabbit RBCs) as well as three cell 
lines of Jurkat (T lymphocytes), B16F10 (malignant melanocytes), and J774.1 (macrophages); the 
characteristics of these four types of cells significantly differ from each other, as summarized in Table 1. 
We have investigated how the silica-induced membranolysis of these cells of different origins is 
influenced by the size and dose of the silica NPs. In order to estimate the affinity of silica surface for 
plasma membranes, we have measured the interaction forces of a silica microsphere with a living cell or 
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a giant unilamellar vesicle (GUV) composed of zwitterionic phosphatidylcholine lipids, using colloid-
probe atomic force microcopy (AFM). 
 
 
2. Materials and methods 
 
2.1. Reagents and culture media 
 
Culture media of RPMI 1640 (11875-093), phenol-red-free RPMI 1640 (11835-030), DMEM (21063-
029, Dulbecco’s modified Eagle medium with 25-mM D-glucose, 4-mM L-glutamine, and 25.03-mM 
HEPES buffer, without sodium pyruvate or phenol red), and DPBS (14190-094, Dulbecco’s phosphate-
buffered saline without calcium or magnesium) were purchased from Life Technologies (Carlsbad, CA, 
USA), and MEM (05900, Eagle’s minimum essential medium with kanamycin, without L-glutamine or 
sodium bicarbonate) was from Nissui Pharmaceutical (Tokyo, Japan). Sodium chloride (NaCl), L-
glutamine, and sodium bicarbonate were purchased from Nacalai Tesque (Kyoto, Japan). Fetal bovine 
serum (FBS; JRH Biosciences, Lenexa, KS, USA) was heat-inactivated in prior to use. 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC) in chloroform (25 mg/mL = 31.8 mM) was purchased from Avanti 
Polar Lipids (Alabaster, AL, USA). Chloroform, acetone, ethanol (Kishida Chemical, Osaka, Japan), 
and methanol (Sigma-Aldrich, St. Louis, MO, USA) were used without further treatment: these reagents 
were of analytical grades. All water used in the experiments was purified using a system composed of 
Elix Advantage 3 (Millipore, Billerica, MA, USA) and WR600A (Yamato Scientific, Tokyo, Japan) to 
give a resistance of 18.2 MΩ cm and a total organic carbon of less than 20 ppb. 
 
2.2. Red blood cells (RBCs) 
 
The red blood cells (RBCs) were collected from rabbit blood preserved in Alsever’s solution (0105-1; 
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Nippon Biotest Laboratories, Tokyo, Japan). The RBCs were gently rinsed three times with DPBS 
through a series of centrifugation (at a gravitational field of 750 g for 5 min), aspiration of the 
supernatant, and redispersion of the remained cell pellet. Consequently, the RBC suspension of 7.5 × 
109 cells/mL was obtained. 
 
2.3. Cell lines and culture conditions 
 
The human lymphocyte cell line of Jurkat (JCRB0147; JCRB Cell Bank, Osaka, Japan) was cultured 
in a complete medium composed of an RPMI 1640 medium, a 1% penicillin-streptomycin mixed 
solution (26253-84; Nacalai Tesque), and 10% FBS. The murine melanoma cell line (B16F10; ATCC 
CRL-6475) was cultured in a complete medium composed of MEM, 2-mM L-glutamine, and 10% FBS; 
additionally, sodium bicarbonate was used to adjust the pH to 7.4. The murine macrophage cell line of 
J774.1 (JCRB0018; JCRB Cell Bank) was cultured in a complete medium composed of an RPMI 1640 
medium and 10% FBS. The non-adherent (Jurkat) and the adherent (B16F10 and J774.1) cells were 
cultivated statically in a flask with nontreated surface (1110-075; IWAKI, Tokyo, Japan) and in a flask 
with tissue culture treated surface (3110-075; IWAKI), respectively; every flask had a culture area of 75 
cm2 and contained 10 mL of the complete medium. These flasks were stored in an incubator, inside 
which a moist atmosphere of 5.0% CO2 was kept at temperature of 37.0 °C. This ensured that the 
complete medium maintained the physiological pH of 7.4. The complete medium for each cell line was 
changed every 2 days. The cells were subcultured every 4 days, when they were grown at the 
concentration of about 1.0 × 106 cells/mL for Jurkat and at the surface density of 1.4 × 105 cells/cm2 for 
B16F10 and 1.3 × 105 cells/cm2 for J774.1. 
 
2.4. Zeta potentials of cells 
 
The electrophoretic mobility of the cells (RBC, Jurkat, B16F10, and J774.1) in 100-mM NaCl 
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solution was measured at room temperature, using a homemade apparatus, where a rectangular silica-
glass cell (10-mm × 1-mm cross section), a cell holder, and a pair of platinum electrodes for Micro-
Electrophoresis Apparatus Mark II (Rank Brothers, Cambridge, UK) were employed. Before the 
measurements, the cells were gently rinsed two times with 100-mM NaCl solution by a series of 
centrifugation, aspiration of the supernatant, and redispersion of the remained cell pellet. The zeta 
potential of the cells was calculated from the mean electrophoretic mobility using Smoluchowski’s 
equation. 
 
2.5. Nanoparticles (NPs) 
 
The green-fluorescent nonporous silica (SiO2) NPs of unmodified surfaces and different diameters 
were purchased from micromod Partikeltechnologie (Rostock Warnemünde, Germany), as listed in 
Table 2. Every silica NP suspension was diluted with three different media depending on the cell lines: 
DPBS for RBCs, phenol-red-free RPMI 1640 for Jurkat and J774.1 cells, and DMEM for B16F10 cells. 
These solutions containing the NPs were prepared at desired concentrations and kept in sterile cryo 
tubes (89050; TPP Techno Plastic Products AG, Trasadingen, Switzerland). The NP-containing 
solutions were stocked in a refrigerator at 5 °C and used within a week after the preparation. Just prior to 
use for exposure of the cells to the NPs, the NP-containing solutions were warmed up at 37.0 °C using a 
water bath (NTT-2000; Tokyo Rikakikai, Tokyo, Japan) and then sonicated for 5 min using an 
ultrasonic cleaning bath 3510J-MT (oscillation frequency 42 kHz, acoustic energy 130 W; Branson 
Ultrasonic, Danbury, CT, USA). Equal volumes of the sonicated NP-containing solutions were filled in 
96-well cell culture plates including 100 µL/well of the NP-free fresh medium, as will be explained in 
Section 2.6. Thus, FBS was never added into the NP-containing solutions throughout the experiments in 
the present study, whereby the effects of serum proteins were eliminated from the experimental results. 
The NPs suspended in 1-mM NaCl solutions or DPBS at 25 °C were characterized with respect of 
hydrodynamic diameters and zeta potentials, using Zetasizer Nano ZS (Malvern Instruments, 
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Worcestershire, UK). In prior to the sample preparation, these liquid media were filtered using the 
surfactant-free cellulose acetate membranes with 0.2-µm pores (155-0020; Nalgene). 
 
2.6. Exposure of cells to NPs 
 
The RBC suspension prepared as in Section 2.2 was filled in a 96-well round-bottom plate with 
nontreated surface (3875-096; IWAKI) to satisfy the liquid volume of 100 µL/well and the concentration 
of 1.5 × 109 cells/mL (i.e., 1.5 × 108 cells/well). Every well was then filled with 100 µL of the NP-
containing DPBS solutions prepared as in Section 2.5. The NP concentrations of the final medium were 
CNP = 0, 200, 400, 800, and 1600 µg/mL, whereas the RBC concentration was 7.5 × 108 cells/mL (5.6% 
hematocrit). The samples were stored in the incubator at 37.0 °C for the exposure period of texp = 4 h. 
The Jurkat cells were seeded in a 96-well round-bottom plate with nontreated surface (3875-096; 
IWAKI). For this subculture, a 10-mL suspension of the cells grown in the 75-cm2 flask prepared as in 
Section 2.3 were put into a 15-mL centrifuge tube (2325-015, IWAKI). The cells were rinsed with 
DPBS after centrifugation (at 750 g for 5 min) and removal of the FBS-supplemented complete medium; 
subsequently, the cells were redispersed in phenol-red-free RPMI 1640 after centrifugation and removal 
of the DPBS, giving a cell suspension of 1.0 × 106 cells/mL. Proper amounts of this cell suspension and 
the NP-free fresh RPMI 1640 were filled in the 96-well plate to satisfy the liquid volume of 100 µL/well 
and the concentration of 3.0 × 105 cells/mL (i.e., 3.0 × 104 cells/well). Every well was then filled with 
100 µL of the NP-containing RPMI 1640 solutions prepared as in Section 2.5. The NP concentrations of 
the final culture medium were CNP = 0, 25, 50, 100, and 200 µg/mL, whereas the Jurkat concentration 
was 1.5 × 105 cells/mL. The samples were stored in the incubator at 37.0 °C for texp = 2 h. Likewise, the 
cell samples at CNP = 0, 1, 2, 10, 20, 100, and 200 µg/mL were prepared and incubated for texp = 24 h. 
The cells of B16F10 (or J774.1) were seeded in a 96-well flat-bottom plate with tissue culture treated 
surface (3860-096; IWAKI). For this subculture of B16F10 (J774.1), the 75-cm2 flask with the 
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subconfluent cells prepared as explained in Section 2.3 was rinsed once (twice) with 10-mL DPBS after 
removal of the FBS-supplemented complete medium; subsequently, the cells were separated from the 
base of the flask by trypsinization with a 1-mL (2-mL) DPBS solution of 0.25% trypsin and 0.02% 
EDTA. A fresh 9-mL (18-mL) complete medium for B16F10 (J774.1) was then added into the flask, 
giving a 10-mL (20-mL) cell suspension of 1.0 × 106 cells/mL (5.0 × 105 cells/mL). Proper amounts of 
this cell suspension and the complete medium were filled in the 96-well plate to satisfy the 
concentration of 4.0 × 104 cells/cm2 (i.e., 1.3 × 104 cells/well) for both B16F10 and J774.1. After 1-day 
incubation, the cell samples of B16F10 (J774.1) were rinsed once (twice) with DPBS after removal of 
the complete medium. After removal of DPBS, every well was filled with 100 µL of the NP-free fresh 
culture medium (DMEM for B16F10 or phenol-red-free RPMI 1640 for J774.1), followed by addition of 
100 µL of the NP-containing culture medium prepared as in Section 2.5. The NP concentrations of the 
final culture medium were CNP = 0, 200, 400, 800, and 1600 µg/mL. The samples were stored in the 
incubator at 37.0 °C for texp = 2 h. Likewise, the cell samples at CNP = 0, 8, 16, 80, 160, 800, and 1600 
µg/mL were prepared and incubated for texp = 24 h. 
 
2.7. Hemolysis assay 
 
The 96-well plate prepared as in Section 2.6 had not only a 200-µL DPBS containing NPs and RBCs 
in each well (1.5 × 108 cells/well), but also a 200-µL DPBS without NPs or RBCs (for the background 
control) and a 200-µL solution with hemolyzed RBCs prepared by mixing a 20-µL cell suspension of 
7.5 × 109 cells/mL and a 180-µL water (for the maximum hemoglobin release control). The 96-well 
plate was then centrifuged at 750 g for 5 min so that the RBCs suspended in the medium settled down. 
100 µL of the supernatant in each well was transferred to a 96-well clear plate with non-binding surface 
(3641; CORNING, Corning, NY, USA). Hemoglobin release in individual wells was recorded by an 
automated plate reader (Infinite M200; Tecan, Grödig, Austria) at a wavelength of 542 nm. Hemolysis 
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was calculated by the formula: 
(Hemoglobin release from treated RBCs) (Medium background)% Hemolysis 100




Every sample was measured at least in triplicate. 
 
2.8. LDH and ATP assays 
 
LDH (lactate dehydrogenase) and ATP (adenosine triphosphate) assays were done using the CytoTox-
ONE homogeneous membrane integrity assay and the CellTiter-Glo luminescent cell viability assay 
(Promega Corporation, Madison, WI, USA), respectively. The 96-well plates prepared as in Section 2.6 
had not only a 200-µL culture medium containing NPs and cells in each well, but also a 200-µL culture 
medium with cells (for the maximum LDH release control and the maximum ATP content control) and 
a 200-µL medium without NPs or cells (for the background control). After incubation for desired 
exposure periods, 10 µL of lysis solution (a 2.7% w/v solution of Triton X-100 in water) was added to 
the wells for the maximum LDH release control. The 96-well plates were then centrifuged at 750 g 
during 5 min for Jurkat or at 100 g during 3 min for B16F10 and J774.1, such that the cells suspended in 
the medium settled down. 
For LDH assay, 100 µL of the supernatant in each well was transferred to a 96-well black plate with 
non-binding surface (3650; CORNING). After being treated according to the manufacturer’s instructions, 
the samples in individual wells were monitored by Infinite M200 with an excitation wavelength of 560 
nm and an emission wavelength of 590 nm. Cytotoxicity was calculated by the formula: 
(LDH release from treated cells) (Culture medium background)% LDH release 100




For ATP assay, the 96-well plates with the remained contents of 100 µL/well were equilibrated at 
22.0 °C for 10 min using an incubator shaker for well plate (MBR-022UP; TAITEC, Saitama, Japan) 
and the equal volume (100 µL) of the CellTiter-Glo reagent was then added to each well, according to 
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the manufacturer’s instructions. After additional 10-min shake/incubation for cell lysis and 
luminescence stabilization, 175 µL of the mixture in each well was transferred to a 96-well white plate 
(3620-096; IWAKI) or a 96-well white plate with non-binding surface (3600; CORNING). The 
luminescence intensities from the samples in individual wells were recorded by Infinite M200 with an 
integration time of 1 s per well. Cell viability was calculated by the formula: 
(ATP content inside treated cells) (Culture medium background)% ATP content 100




Every sample was measured at least in triplicate for LDH and ATP assays. 
 
2.9. Confocal laser scanning microscopy (CLSM) 
 
As for the non-adherent cells (RBC and Jurkat), a mixed suspension of the cells and the NPs was 
prepared as mentioned in Section 2.6, but was put in a 4-mL sterile culture tube (2235-012N; IWAKI) 
other than the 96-well plate. The final concentration of this mixture was 7.5 × 105 cells/mL for RBC and 
1.5 × 105 cells/mL for Jurkat. After incubation at 37.0 °C, 1 mL of the mixture was the transferred to a 
sterile microtube, and the cells were gently rinsed two times with a fresh medium (DPBS for RBC and 
phenol-red-free RPMI 1640 for Jurkat) through a series of centrifugation (at 400 g for 5 min), aspiration 
of the supernatant, and redispersion of the remained cell pellet. A suspension of the rinsed cells was 
added into a φ  35-mm dish with φ 12-mm glass bottom (3911-035; IWAKI). On the other hand, the 
samples of the adherent cells (B16F10 and J774.1) for CLSM were prepared as described elsewhere [47]. 
The differential interference contrast (DIC) and the fluorescence images of the cell samples were 
obtained by CLSM (C1si-ready mounted on TE2000-E; Nikon, Tokyo, Japan) with the water-immersion 
objective 60× of N.A. = 1.20 (VC60×WI; Nikon). 
 




GUVs were prepared following Ref. [48]. Briefly, 60-µL chloroform solution of DOPCs (31.8 mM) 
was admixed with a mixture of 940-µL chloroform and 150-µL methanol in a 50-mL round-bottom 
evaporation flask. The aqueous phase (7 mL of water or DPBS) was then prudently added along the 
flask wall. This two-phase solution was left over 60 min at room temperature. The organic solvent was 
rotoevaporated for 5−10 min under reduced pressure (down to the final pressure ≈17 mbar) at 40 °C and 
40 rpm, using a rotary evaporator (R-215, V-700, V-850, and B-491; BUCHI Labortechnik, Flawil, 
Switzerland) with a recirculating chiller (NCB-2500; Tokyo Rikakikai). During this rotoevaporation, 
two major boiling events were observed at the pressures of 450−380 mbar and 150−80 mbar, where 
chloroform and methanol mainly evaporated, respectively. The resulting aqueous solution (5.5−6 mL) 
was opalescent and contained GUVs with diameters ranging from 1 to 60 µm, as observed by light 
microscopy. 
The prepared solution of GUVs was filtered, using a φ 25-mm syringe filter of surfactant-free 
cellulose acetate membrane with 0.2-µm pore (190-2520; Nalgene). The SUVs in the obtained solution 
were characterized in terms of hydrodynamic diameter and zeta potential, using Zetasizer Nano ZS. 
 
2.11. Atomic force microscopy (AFM) and colloid probes 
 
Before fabrication of colloid probes, the nonporous silica microspheres of typical 20-µm diameter 
(Quartron SP-25B; FUSO CHEMICAL, Osaka, Japan) were thoroughly washed as follows. A powder of 
the silica microspheres was dispersed in a 10-mL Teflon FEP centrifuge tube containing ethanol at 50°C. 
After 5-min stirring, the silica microspheres were washed three times with water. The collected 
microspheres were dispersed in a 5% H2O2 aqueous solution at 50°C. After 5-min stirring and three-
times washing with water, the collected microspheres were dispersed in a 5-mM NaOH aqueous 
solution at room temperature. After 5-min stirring and three-times washing with water, the collected 
microspheres were dried in vacuum and stored in a clean tube. 
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An AFM probe (OMCL-TR400PSA; Olympus, Tokyo, Japan), which has a V-shaped, 100-µm long 
cantilever with a spring constant of the nominal value 0.08 N/m and with an Si3N4 pyramidal tip on its 
end, was rinsed with a series of acetone, ethanol, and water. The spring constant of every cantilever was 
calibrated by the thermal method and found to be 0.05−0.12 N/m. Out of the washed silica microspheres, 
a single microsphere of about 10-µm diameter was selectively glued to the end of the cantilever [49,50]. 
Immediately prior to AFM measurements, the surfaces of the colloid probes were further cleaned by 
plasma treatment for 5 min in an argon−water moisture atmosphere at 5 W, using a basic plasma kit 
(BP-1; SAMCO, Kyoto, Japan) combined with a 13.56-MHz radio frequency plasma generator (ENI 
ACG-3B). 
An MFP-3D-BIO AFM system (Asylum Research, Santa Barbara, CA, USA) was used to measure the 
interaction forces between a silica surface of the colloid probe and a soft surface of a living cell or a 
GUV in the aqueous phase at room temperature in an air-conditioned laboratory (23 ± 2 °C). As for 
living cells (see Fig. 5a), the AFM measurements were carried out in the same way as described in Ref. 
[50], except for several conditions; in the present study, the glass-bottom dishes (GWSt-5040; WillCo 
Wells B.V., Amsterdam, the Netherlands) were used. 
As for GUVs, three copper grids of 3-mm diameter and 15−20-µm thickness with DN300 square 
mesh (83-µm pitch, 45-µm hole width, 38-µm bar width; Okenshoji, Tokyo, Japan) were placed on a 
coverslip (35-mm round, No. 1S thickness; Matsunami Glass, Osaka, Japan) held by a fluid cell, and 
then 2 mL of the aqueous phase containing GUVs was added to the fluid cell; immediately prior to this 
use, the grids and coverslip were plasma-treated for 5 min. The fluid cell was placed on the AFM base 
(the XY-scanner equipped with the manual XY-translation stage), under which an inverted light 
microscope was placed; this allowed us to check whether single GUVs were trapped in some individual 
holes of the grids or not. The cantilever with the colloid probe was fixed on the AFM head (the Z-
scanner) via the cantilever holder and immersed in the aqueous phase. Prior to the force measurements, 
the optical lever sensitivity was determined at the positions far from the grids, whereby the surface 
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cleanliness of the colloid probe was checked at the same time. A GUV of 40-µm diameter trapped in a 
grid’s hole was selectively positioned right under the colloid probe, using the XY-translation stage (see 
Fig. 5b). Thus, we started the force measurements at Z-scan speed of 1.3 µm/s, which was slow enough 





3.1. Characterization of silica NPs, vesicles, and cells 
 
Table 2 summarizes the results of characterization of the silica NPs, the DOPC vesicles, and the cells 
employed in the present study. Every type of the NPs suspended in 1-mM NaCl solution exhibited the 
relatively small PDI (= 0.01−0.09) and the significantly large zeta potential in magnitude (= 35−73 mV). 
The Z-average diameter and PDI of the NPs in DPBS were almost the same as those in 1-mM NaCl 
solution, although the NPs in DPBS exhibited the small zeta potentials in magnitude (= 19−27 mV) 
compared with those in 1-mM NaCl solution. These results suggest that the silica NPs stably dispersed 
not only in 1-mM NaCl solution, but also in DPBS of a high ionic strength (150 mM) without 
significant aggregation. The culture medium of RPMI 1640 and DMEM had almost the same ionic 
strength (~140 mM) and the same pH (=7.0−7.4) as DPBS, indicating that the silica NPs listed in Table 
2 stably dispersed in the culture medium of RPMI 1640 and DMEM as well. 
The vesicles of zwitterionic DOPCs in water and DPBS had negatively charged surfaces: the latter 
exhibited the small zeta potentials in magnitude compared with the former. The cellular surfaces of RBC, 
Jurkat, B16F10, and J774.1 employed were negatively charged in an aqueous solution of physiological 




It is worth noting that the status of glycocalyx layer on the plasma membrane of mammalian cells 
could influence the cellular responses to particles, though it was not characterized in the present study. 
In addition, subcultured adherent cell lines often lack their intact glycocalyx layers due to the use of 
trypsin. Therefore, the subcultured adherent cells (B16F10 and J774.1) after trypsinization were pre-
incubated in FBS-supplemented complete media for 1 day before exposure to NPs (see Sections 2.6 and 
2.9) and the cell−microsphere interaction force measurements (see Section 2.11). Such pre-incubation 
allowed the adherent cells to recover their glycocalyx layers to some extent, which would diminish the 
impact of trypsinization on the adherent cells. 
 
 
3.2. Cytotoxicity and cell viability after 24-hours exposure to silica NPs 
 
Panels a−c of Fig. S1 display the cellular responses after 24-hours exposure to different silica NPs as 
a function of the NP mass dose for Jurkat, B16F10, and J774.1, respectively. It is noted that the 
population doubling times of these cell lines were about 20−30 hours in NP-free, FBS-supplemented 
culture media. In the case of 24-hours exposure of these mammalian cells to the NPs, the LDH release is 
associated with the cytotoxicity, whereas the ATP content is related to the cell viability. As shown in Fig. 
S1a for Jurkat, the cytotoxicity increased and the cell viability decreased as the NP mass dose of every 
type of the silica NPs increased up to a certain value, and then they became almost constant, indicating 
that the cytotoxicity and the cell viability were correlated with each other. The smaller NPs exhibited the 
higher cytotoxicity and the less viability. These dose- and size-dependent behaviors of cytotoxicity and 
cell viability were found in Fig. S1b for B16F10 and Fig. S1c for J774.1 as well. It is noted that the 
LDH release from Jurkat and J774.1 was not negligible even in the NP-free culture media, which would 
be a consequence resultant from living and proliferation of the cells. Similar behaviors of cytotoxicity 
and cell viability have been reported for endothelial cells [27,38], keratinocytes [42], and macrophages 
[25-27], where the cells were treated with silica NPs in serum-free media for 24 hours. 
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Once the exposure dose was converted to the equivalent NP surface area per suspension volume, the 
results of cytotoxicity (or cell viability) for silica NPs of different sizes were apparently represented by a 
master curve, as shown in panels a−c of Fig. 1 for Jurkat, B16F10, and J774.1, respectively. A similar 
scaling behavior of the cellular responses to silica NPs in serum-free culture media has been reported for 
endothelial cells [38] and macrophages [26]. Henceforth, the NP surface area per suspension volume is 
referred to as the NP surface area dose in the present study. 
 
3.3. CLSM images of cells after exposure to silica NPs within a few hours 
 
Using CLSM, the cells were observed after being exposed to the silica NPs within a few hours. The 
typical CLSM images are displayed in Fig. 2. The non-adherent cells of Jurkat and RBC settled down 
onto the substrate (see panels a and d of Fig. 2), whereas the cells of B16F10 and J774.1 were strongly 
adhered on the substrate (see panels b and c of Fig. 2). It is noted that the nucleated cells (Jurkat, 
B16F10, and J774.1) have the outer surfaces with microvilli [49,51] or membrane wrinkles [52], 
whereas the surface of RBC does not exhibit such microstructures [53]; thus, the outer surfaces of the 
nucleated cells are rather rough compared with that of RBC. Regardless of cell types, the silica NPs 
were mainly observed near the plasma membranes, but rarely found in the cytoplasmic region as well as 
the nuclear region. Similar results for RBCs were reported by Zhao et al. [8], where porous silica NPs 
were employed instead of nonporous silica NPs. 
 
3.4. Membrane integrity and metabolic activity of cells after 2-hours exposure to silica NPs 
 
Panels a−c of Fig. S2 display the cellular responses after 2-hours exposure to different silica NPs as a 
function of the NP mass dose for Jurkat, B16F10, and J774.1, respectively. Because of the short-time 
exposure to the NPs, the LDH release is associated with the membrane integrity of cells, while the ATP 
content is related to the metabolic activity of cells. The dose- and size-dependent behaviors of LDH 
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release and ATP content were observed for every cell line. The reverse correlation between these two 
cellular responses indicates that the membrane integrity and the metabolic activity of the cells after 
exposure to the silica NPs were correlated with each other. The smaller silica NPs exhibited the greater 
lytic ability, where the cell membrane was disrupted and ruptured within a few hours (see also panels 
a−c of Fig. 2). 
After being replotted as a function of NP surface area dose, the results of LDH release (or ATP 
content) appeared to be represented by a master curve regardless of the NP diameter, as shown in panel 
a−c of Fig.3 for Jurkat, B16F10, and J774.1, respectively. Thus, a scaling behavior of the short-time 
cellular responses to high-dose silica NPs in serum-free culture media was observed for three different 
cell lines (Jurkat, B16F10, and J774.1) in a wide range of NP diameters (28–461 nm); nonetheless, the 
large silica NPs of 461-nm diameter exhibited no significant impact on the adherent cells of B16F10 and 
J774.1. 
 
3.5. Hemolysis by silica NPs 
 
Figure 4 displays the hemolysis by 4-hours exposure to different silica NPs. As shown in Fig. 4a, the 
hemolysis increased with NP mass dose of the silica NPs, and became more significant for the smaller 
NPs. Once the exposure dose was converted to the equivalent NP surface area per suspension volume as 
in Fig. 4b, the dose- and size- dependent hemolytic activities of the silica NPs seemed to be on a master 
curve regardless of the NP diameter in the range of 50−461 nm. 
The very early study [13] reported that hemolysis does not occur with 3- or 4-nm silica NPs, but does 
occur with 5-nm NPs and the hemolytic activity increases with NP diameter ranging from 5 to 30 nm. 
This size dependence is diametrically opposite to those of Ref. [7] for 24−263 nm and of Fig. 4a for 
50−461 nm. The contradiction between these results could originate from the difference in the size 
ranges of the employed NPs, although it remains to be explored. 
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 3.6. Surface forces between a silica microsphere and a living cell or a GUV 
 
In order to estimate the affinity of silica surface for plasma membranes, we performed the AFM 
measurements of the interaction forces between a 10-µm silica microsphere and a living B16F10 cell 
(see Fig. 5a) or a GUV composed of DOPCs (see Fig. 5b). 
In Fig. 5c, the force curve for silica−cell interaction during compression displayed zero force at the 
distances longer than ~2 µm. The repulsion at the distances shorter than ~2 µm probably originated from 
both steric stabilization forces and viscoelastic forces; the former are caused by the compression of a 
dense lawn of microvilli on the cell surface [49] as well as a hydrated layer of long-chain polymer 
molecules (proteins and carbohydrates) thereon, while the latter result from the viscoelastic property of a 
cell [54]. After compression, the decompression force curve, which is the result of detachment of a 
microsphere from the apical surface of a cell, showed an initial de-adhesion peak at the distance of ~1 
µm followed by several small steps of 20−40 pN, indicating that the silica surface adhered onto the 
apical membrane of the B16F10 cell. The small steps are attributable to the breaking of the multiple 
bonds formed at different locations of close contact between the cell and silica surfaces. 
By contrast, both the compression and decompression force curves for silica−GUV interaction in 
DPBS were entirely repulsive, as shown in Fig. 5d. Similar results were obtained in water (data not 
shown). The repulsion at the distances shorter than ~1.2 µm was mainly originated from elastic property 





RBC, Jurkat, B16F10, and J774.1 were employed as target cells for amorphous silica NPs of different 
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diameters (28, 50, 55, 156, and 461 nm). These four types of mammalian cells have distinctive 
characteristics in terms of nucleated/non-nucleated cells, adherent/non-adherent cells, endocytosis, and 
phagocytosis, as summarized in Table 1. Despite of the fundamental differences among them, these cells 
had some similarities in their short-time responses to high-dose silica NPs in serum-free culture media, 
as shown in Figs. 2−4: (i) the silica NPs strongly adhered onto the cell membrane to disrupt and rupture 
it, (ii) this silica-induced membranolysis occurred within a few hours and increased with decreasing NP 
diameter and increasing NP mass dose, and (iii) the size- and dose-dependent membranolytic activity of 
the silica NPs appeared to be represented by a master curve as a function of the NP surface area per 
suspension volume regardless of the NP diameter. After 24-hours exposure to silica NPs, the nucleated 
cells of Jurkat, B16F10, and J774.1 responded, as shown in Fig. 1: (i) the cytotoxicity increased and the 
cell viability decreased with decreasing NP diameter and increasing NP mass dose, and (ii) the size- and 
dose-dependent cellular responses were apparently represented by a master curve as a function of the NP 
surface area per suspension volume regardless of the NP diameter. The cellular response after a-few-
hours exposure reflected that after 24-hours exposure, although the latter was a consequence resultant 
from complex cellular behaviors such as adhesion/uptake of silica NPs onto/into cells, silica-induced 
membranolysis, recovery of the damaged cells, and proliferation of the survived cells. The scaling 
behaviors of Figs. 3 and 4b as well as the CLSM images of Fig. 2 suggest that the membranolytic ability 
of silica NPs is related to the surface density and distribution of the negatively charged silanol (Si−OH) 
groups that are accessible to the cell membrane, irrespective of mammalian cell types. This is supported 
by the finding in Refs. [5,6]: the hemolytic activity of the porous silica NPs and the surface-modified 
silica NPs is considerably reduced compared to that of the nonporous bare silica NPs. 
As shown in Table 2, the silica NPs, the DOPC vesicles, and the mammalian cells had the negatively 
charged surfaces on average in aqueous solutions of physiological ionic strength; indeed, the net 
interaction force between the silica and cell surfaces was not attractive or adhesive until they came into 
closer contact with each other, as shown in Fig. 5c. Considering the adhesive forces between them 
during decompression shown in Fig. 5c and the nature of cell membrane [55], however, it has been 
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postulated that membranolysis of mammalian cells is originated by strong adsorption of membrane 
components onto the surface of silica NPs. The cell membrane is composed of a phospholipid bilayer 
with incorporated cholesterol and embedded proteins. Phospholipids consist of two long hydrophobic 
hydrocarbon chains attached to a hydrophilic polar head group. The head group contains of a negatively 
charged phosphate moiety and, often, a primary or quaternary amine moiety. It is noted that a major 
constituent of cell membranes is phosphatidylcholine (PC), which has a zwitterionic head group of the 
phosphate ester (−R(PO4−)R’−) and the quaternary amine (−N(CH3)3+) moieties and is more commonly 
found in the exoplasmic leaflet of a cell membrane. 
The interactions of silica particles with protein-free bilayers of PC have been investigated by the 
leakage of entrapped tracers from liposomes [56-58], the adsorption isotherms [57-62], the nuclear 
magnetic resonance (NMR) spectroscopy [63], the cryogenic transmission electron microscopy (Cryo-
TEM) [64], the fluorescence microscopy and isothermal titration calorimetry [65], and the calorimetry, 
electrophoresis, dynamic light scattering (DLS), and Cryo-TEM [66,67]. The interactions of silica 
particles with supported membranes of PC have been studied by the electrochemistry and calorimetry 
[68] and the electrophysiology and fluorescence microscopy [69]. In addition to the particulate silica, the 
interactions of silica substrates with PC liposomes [70] have been studied by quartz crystal 
microbalance (QCM) [71-73] and AFM [62,74]. These studies indicate that affinity of the bare silica 
surface for neutral PCs is rather weak and mainly attributed to van der Waals forces [58-62,68], which is 
consistent with the results of our AFM measurements shown in Fig. 5d. Consequently, it is most likely 
assumed that the exoplasmic portions of membrane proteins are strongly adsorbed onto the surfaces of 





Four types of mammalian cells (RBC, Jurkat, B16F10, and J774.1) were employed as target cells for 
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amorphous silica NPs of different diameters (28, 50, 55, 156, and 461 nm). These different cells had 
some similarities in their short-time responses to high-dose silica NPs in serum-free culture media: (i) 
the silica NPs strongly adhered onto the cell membrane to disrupt and rupture it, (ii) this silica-induced 
membranolysis occurred within a few hours and increased with decreasing NP diameter and increasing 
NP mass dose, and (iii) the size- and dose-dependent membranolytic activity of the silica NPs appeared 
to be represented by a master curve as a function of the NP surface area per suspension volume 
regardless of the NP diameter. The results of our AFM measurements shown in Fig. 5 imply that the 
exoplasmic portions of membrane proteins are strongly adsorbed onto the surfaces of silica particles, 
which leads to membranolysis of mammalian cells. 
It should be noted that the applied doses of particles in the present in vitro study are much larger than 
anticipated exposures in vivo; this is the case for most of the other in vitro studies. Also, the history of 
particles before their interaction with target cells in vivo will be different depending on kinds of the 
targets; for example, (i) the particles in lung will interact with alveolar macrophages via pulmonary 
surfactants and (ii) the particles in a blood vessel will interact with blood cells via various serum 
proteins. Such biomolecules can modulate the outcome. In this sense, our findings mentioned above, 
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Fig. 1.  LDH release (upper panels) and ATP content (lower panels) of three different cells as a function 
of NP surface area dose after 24-hours exposure to Silica-30 and -200 NPs (see Table 2): (a) Jurkat, (b) 
B16F10, and (c) J774.1. The dashed lines in upper and lower panels represent the percentages of LDH 
release and ATP content in the NP-free medium, respectively. The collected data of these assays were 
expressed as the mean ± standard error of mean. 
Fig. 2.  Differential interference contrast images (upper panels) and fluorescence images of the optical 
section (lower panels) of four different cells after exposure to Silica-70 NPs: (a) Jurkat at CNP = 200 
µg/mL after texp = 2.0 h; (b) B16F10 at CNP = 200 µg/mL after texp = 1.0 h; (c) J774.1 at CNP = 200 
µg/mL after texp = 1.0 h; (d) RBC at CNP = 100 µg/mL after texp = 0.5 h. The scale bars in panels a−d are 
10, 20, 10, and 2 µm, respectively. 
Fig. 3.  LDH release (upper panels) and ATP content (lower panels) of three different cells as a function 
of NP surface area dose after 2-hours exposure to Silica-30, -70, -200, and -500 NPs (see Table 2): (a) 
Jurkat, (b) B16F10, and (c) J774.1. The dashed lines in upper and lower panels represent the percentages 
of LDH release and ATP content in the NP-free medium, respectively. The collected data of these assays 
were expressed as the mean ± standard error of mean. 
Fig. 4.  (a) Hemolysis of RBCs as a function of NP mass dose, CNP, after 4-hours exposure to Silica-50, 
-70, -200, and -500 NPs (see Table 2). The solid lines are the guides for the eyes. (b) Same as panel a, 
but plotted as a function of NP surface area dose, where the dashed line represents the hemolysis in the 
NP-free medium. The collected data of hemolysis assay were expressed as the mean ± standard error of 
mean. 
Fig. 5.  (a,b) Illustration of AFM measurements of interaction forces between the microsphere and soft 
sample: (a) a living cell and (b) a GUV. (c,d) A representative of the force–displacement curves during 
compression (upper, red colored) and decompression (lower, blue colored) measured between a 10-µm 
silica microsphere and a soft sample at the Z-scan speed of 1.0−1.3 µm/s with no dwell time: (c) a 
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B16F10 cell in a serum-free culture medium of DMEM and (d) a 40-µm GUV composed of DOPCs in 
DPBS containing vesicles, where the inset represents the magnification of the forces ranging from −0.2 




The properties of vesicles and mammalian cells employed in the present study. 
Cell Membrane 
proteins 
Nucleated Adherent Endocytosis Phagocytosis 
DOPC vesicles No No No No No 
Erythrocyte (RBC) Yes No No No No 
Jurkat Yes Yes No Yes No 
B16F10 Yes Yes Yes Yes No 





The results of characterization of the silica NPs, the SUVs, and the cells at 25.0 °C. 
Dispersoid Medium Z-average diameter 
(nm)a 
PDIb Zeta potential  
(mV) a 
Silica-30 1-mM NaCl 28 ± 1 0.09 −35 ± 1 
 DPBS 30 ± 1 0.21 −20 ± 1 
Silica-50 1-mM NaCl 50 ± 1 0.04 −37 ± 2 
 DPBS 50 ± 1 0.07 −19 ± 1 
Silica-70 1-mM NaCl 55 ± 1 0.04 −39 ± 2 
 DPBS 55 ± 1 0.06 −19 ± 1 
Silica-200 1-mM NaCl 156 ± 1 0.01 −57 ± 1 
 DPBS 152 ± 1 0.02 −27 ± 2 
Silica-500 1-mM NaCl 461 ± 5 0.02 −73 ± 1 
 DPBS 476 ± 7 0.03 −26 ± 2 
DOPC SUVs water 161 ± 5 0.39 −25 ± 1 
 DPBS 232 ± 4 0.41 −7 ± 1 
Rabbit RBCs 100-mM NaCl 6 ± 1 µmc  −9 ± 1 
Jurkat cells 100-mM NaCl 11 ± 5 µmc  −11 ± 1 
B16F10 cells 100-mM NaCl 13 ± 5 µmc  −14 ± 2 
J774.1 cells 100-mM NaCl 14 ± 2 µmc  −16 ± 1 
a The collected data were expressed as the mean ± standard deviation (s.d.). 
b Polydispersity index. 
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Fig. 1S.  LDH release (upper panels) and ATP content (lower panels) of three different cells as a 
function of NP mass dose, CNP, after 24-hours exposure to Silica-30 and -200 NPs (see Table 2): (a) 
Jurkat, (b) B16F10, and (c) J774.1. The dashed lines in upper and lower panels represent the 
percentages of LDH release and ATP content in the NP-free medium, respectively. The collected 
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Fig. 2S.  LDH release (upper panels) and ATP content (lower panels) of three different cells as a 
function of NP mass dose, CNP, after 2-hours exposure to Silica-30, -70, -200, and -500 NPs (see 
Table 2): (a) Jurkat, (b) B16F10, and (c) J774.1. The dashed lines in upper and lower panels 
represent the percentages of LDH release and ATP content in the NP-free medium, respectively. The 
collected data of these assays were expressed as the mean ± standard error of mean. 
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